Skip to main
CARL

Carlsmed Inc (CARL) Stock Forecast & Price Target

Carlsmed Inc (CARL) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Carlsmed is a promising company with strong leadership, innovative AI technology, and a growing market reach. The company's financials and patent portfolio position them for sustained double-digit growth and profitability, while their active surgeon base and residency program provide potential for further expansion and development. With a Buy rating and a price target of $23, Carlsmed is poised for success in the medical technology industry.

Bears say

Carlsmed is a young company with a limited operating history and a highly competitive market environment, which could limit their ability to gain or hold onto market share despite their patented technology and positive physician feedback. Additionally, high pressure for profitability and potential reimbursement challenges could hinder their growth potential and make it difficult for them to stay afloat in a crowded market.

Carlsmed Inc (CARL) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Carlsmed Inc (CARL) Forecast

Analysts have given Carlsmed Inc (CARL) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Carlsmed Inc (CARL) has a Strong Buy consensus rating as of Jul 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Carlsmed Inc (CARL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.